EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist

Jérémie Le Pen iD, Gabrielle Paniccia, Volker Kinast, Marcela Moncada-Velez, Alison W Ashbrook, Michael Bauer, H-Heinrich Hoffmann, Ana Pinharanda, Inna Ricardo-Lax, Ansgar F Stenzel, Edwin A Rosado-Olivieri, Kenneth H Dinnon und 27 weitere

PLOS Biology · 24.09.2024 · 22 (9) · e3002767

DOI: 10.1371/journal.pbio.3002767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 24.09.2024. Verfasst von Jérémie Le Pen und 38 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America. Hauptthemen laut MEDLINE: SARS-CoV-2, Virus Internalization, COVID-19. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferons (IFNs) play a crucial role in the regulation and evolution of host–virus interactions. Here, we conducted a genome-wide arrayed CRISPR knockout screen in the presence and absence of IFN to identify human genes that influence Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. We then performed an integrated analysis of genes interacting with SARS-CoV-2, drawing from a selection of 67 large-scale studies, including our own. We identified 28 genes of high relevance in both human genetic studies of Coronavirus Disease 2019 (COVID-19) patients and functional genetic screens in cell culture, with many related to the IFN pathway. Among these was the IFN-stimulated gene PLSCR1 . PLSCR1 did not require IFN induction to restrict SARS-CoV-2 and did not contribute to IFN signaling. Instead, PLSCR1 specifically restricted spike-mediated SARS-CoV-2 entry. The PLSCR1-mediated restriction was alleviated by TMPRSS2 overexpression, suggesting that PLSCR1 primarily restricts the endocytic entry route. In addition, recent SARS-CoV-2 variants have adapted to circumvent the PLSCR1 barrier via currently undetermined mechanisms. Finally, we investigate the functional effects of PLSCR1 variants present in humans and discuss an association between PLSCR1 and severe COVID-19 reported recently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Virus InternalizationCOVID-19HumansHEK293 CellsCRISPR-Cas SystemsSpike Glycoprotein, CoronavirusSerine EndopeptidasesInterferonsClustered Regularly Interspaced Short Palindromic RepeatsAntigens, Differentiation

Substanzen

leu-13 antigenTMPRSS2 protein, humanSpike Glycoprotein, CoronavirusSerine EndopeptidasesInterferonsspike protein, SARS-CoV-2Antigens, Differentiation

Autor:innen und Institutionen

  • Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.
  • Department of Medical Microbiology and Virology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
  • Department for Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany.
  • St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.
  • Department of Biological Sciences, Columbia University, New York, New York, United States of America.
  • Laboratory of Synthetic Embryology, The Rockefeller University, New York, New York, United States of America.

ORCID-Profile: Jérémie Le Pen

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Le Pen, J., Paniccia, G., Kinast, V., Moncada-Velez, M., Ashbrook, A. W., Bauer, M., Hoffmann, H. H., Pinharanda, A., Ricardo-Lax, I., Stenzel, A. F., Rosado-Olivieri, E. A., Dinnon, K. H., Doyle, W. C., Freije, C. A., Hong, S. H., Lee, D., Lewy, T., Luna, J. M., Peace, A., …, & Rice, C. M. (2024). A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist. PLOS Biology, 22(9), e3002767. https://doi.org/10.1371/journal.pbio.3002767

Vancouver

Le Pen J, Paniccia G, Kinast V, Moncada-Velez M, Ashbrook AW, Bauer M, et al. A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist. PLOS Biology. 2024;22(9):e3002767. doi:10.1371/journal.pbio.3002767

BibTeX
@article{LePen2024,
  author = {Le Pen, Jérémie and Paniccia, Gabrielle and Kinast, Volker and Moncada-Velez, Marcela and Ashbrook, Alison W and Bauer, Michael and Hoffmann, H-Heinrich and Pinharanda, Ana and Ricardo-Lax, Inna and Stenzel, Ansgar F and Rosado-Olivieri, Edwin A and Dinnon, Kenneth H and Doyle, William C and Freije, Catherine A and Hong, Seon-Hui and Lee, Danyel and Lewy, Tyler and Luna, Joseph M and Peace, Avery and Schmidt, Carltin and Schneider, William M and Winkler, Roni and Yip, Elaine Z and Larson, Chloe and McGinn, Timothy and Menezes, Miriam-Rose and Ramos-Espiritu, Lavoisier and Banerjee, Priyam and Poirier, John T and Sànchez-Rivera, Francisco J and Cobat, Aurélie and Zhang, Qian and Casanova, Jean-Laurent and Carroll, Thomas S and Glickman, J Fraser and Michailidis, Eleftherios and Razooky, Brandon and MacDonald, Margaret R and Rice, Charles M},
  title = {A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist},
  journal = {PLOS Biology},
  year = {2024},
  volume = {22},
  number = {9},
  pages = {e3002767},
  doi = {10.1371/journal.pbio.3002767}
}
Kostenlos starten →